UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 746

Sortiert nach

Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

The New England journal of medicine, 2018-03, Vol.378 (12), p.1107-1120

2018

Volltextzugriff (PDF)

Understanding the role of iron in the magnetism of Fe doped ZnO nanoparticles

Physical chemistry chemical physics : PCCP, 2015-06, Vol.17 (23), p.15284-15296

2015

Volltextzugriff (PDF)

Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study

Journal of clinical oncology, 2019-02, Vol.37 (4), p.269-277

2019

Volltextzugriff (PDF)

Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM

Blood, 2017-11, Vol.130 (22), p.2392-2400

2017

Volltextzugriff (PDF)

Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models

Molecular cancer therapeutics, 2016-05, Vol.15 (5), p.1132-1144

2016

Volltextzugriff (PDF)

Molecular biomarker analyses using circulating tumor cells

PloS one, 2010-09, Vol.5 (9), p.e12517-e12517

2010

Volltextzugriff (PDF)

Evidence of Ferromagnetic Signal Enhancement in Fe and Co Codoped ZnO Nanoparticles by Increasing Superficial Co3+ Content

Journal of physical chemistry. C, 2014-06, Vol.118 (24), p.13203-13217

2014

Volltextzugriff (PDF)

Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3' Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical Models

Clinical cancer research, 2010-07, Vol.16 (14), p.3670-3683

2010

Volltextzugriff (PDF)

Considerations in the development of circulating tumor cell technology for clinical use

Journal of translational medicine, 2012-07, Vol.10 (1), p.138-138, Article 138

2012

Volltextzugriff (PDF)

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL

Nature medicine, 2007-09, Vol.13 (9), p.1070-1077

2007

Volltextzugriff (PDF)

Defect induced ferromagnetism in undoped ZnO nanoparticles

Journal of applied physics, 2014-05, Vol.115 (17)

2014

Volltextzugriff (PDF)

Combination of Defects Plus Mixed Valence of Transition Metals: A Strong Strategy For Ferromagnetic Enhancement in ZnO Nanoparticles

Journal of physical chemistry. C, 2016-04, Vol.120 (16), p.8969-8978

2016

Volltextzugriff (PDF)

Correlation between saturation magnetization, bandgap, and lattice volume of transition metal (M=Cr, Mn, Fe, Co, or Ni) doped Zn1−xMxO nanoparticles

Journal of applied physics, 2010-05, Vol.107 (9)

2010

Volltextzugriff (PDF)

Increased exposure to loading is associated with decreased plantar soft tissue hardness in people with diabetes and neuropathy

Diabetes research and clinical practice, 2022-05, Vol.187, p.109865-109865, Article 109865

2022

Volltextzugriff (PDF)

Carrier-controlled ferromagnetism in transparent oxide semiconductors

Nature materials, 2006-04, Vol.5 (4), p.298-304

2006

Volltextzugriff (PDF)

Room-temperature ferromagnetism in chemically synthesized Sn1−xCoxO2 powders

Applied physics letters, 2004-08, Vol.85 (9), p.1559-1561

2004

Volltextzugriff (PDF)

Flow diagram of the metal-insulator transition in two dimensions

Nature physics, 2007-10, Vol.3 (10), p.707-710

2007

Volltextzugriff (PDF)

Plasma Induced Transcriptional Analysis Assessment of Rejection in Pediatric Heart Transplantation

The Journal of heart and lung transplantation, 2020-04, Vol.39 (4), p.S222-S222

2020

Volltextzugriff (PDF)

whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis

Proceedings of the National Academy of Sciences - PNAS, 2011-10, Vol.108 (43), p.E943-E951

2011

Volltextzugriff (PDF)

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma

Blood, 2017-11, Vol.130 (22), p.2401-2409

2017

Volltextzugriff (PDF)

Dopant spin states and magnetism of Sn1−xFexO2 nanoparticles

Journal of applied physics, 2014-05, Vol.115 (17)

2014

Volltextzugriff (PDF)

Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial

The lancet oncology, 2020-12, Vol.21 (12), p.1630-1642

2020

Volltextzugriff (PDF)

Possible metamagnetic origin of ferromagnetism in transition-metal-doped SnO2

Journal of applied physics, 2005-05, Vol.97 (10)

2005

Volltextzugriff (PDF)

Development of high-temperature ferromagnetism in SnO2 and paramagnetism in SnO by Fe doping

Physical review. B, Condensed matter and materials physics, 2005-08, Vol.72 (5), p.054402.1-054402.14

2005

Volltextzugriff (PDF)

Effect of Co doping on the structural, optical and magnetic properties of ZnO nanoparticles

Journal of physics. Condensed matter, 2007-07, Vol.19 (26), p.266203-266203

2007

Volltextzugriff (PDF)

1 – 25 von 746

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(633)
Mit Volltextzugriff
(664)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Englisch
(726)
Japanisch
(54)
Deutsch
(2)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(345)
Physical Sciences
(152)
Life Sciences & Biomedicine
(145)
Humans
(130)
Technology
(108)
Physics
(102)
Physics, Applied
(73)
Materials Science
(72)
Chemistry
(61)
Female
(57)
Materials Science, Multidisciplinary
(54)
Male
(51)
Engineering
(41)
Adult
(37)
Physics, Condensed Matter
(36)
Middle Aged
(33)
Science & Technology - Other Topics
(32)
Exact Sciences And Technology
(31)
Nanoparticles
(31)
Cardiac & Cardiovascular Systems
(30)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

Venetoclax–Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia

Understanding the role of iron in the magnetism of Fe doped ZnO nanoparticles

Fixed Duration of Venetoclax-Rituximab in Relapsed/Refractory Chronic Lymphocytic Leukemia Eradicates Minimal Residual Disease and Prolongs Survival: Post-Treatment Follow-Up of the MURANO Phase III Study

Promising efficacy and acceptable safety of venetoclax plus bortezomib and dexamethasone in relapsed/refractory MM

Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma Models

Molecular biomarker analyses using circulating tumor cells

Evidence of Ferromagnetic Signal Enhancement in Fe and Co Codoped ZnO Nanoparticles by Increasing Superficial Co3+ Content

Predictive Biomarkers of Sensitivity to the Phosphatidylinositol 3' Kinase Inhibitor GDC-0941 in Breast Cancer Preclinical Models

Considerations in the development of circulating tumor cell technology for clinical use

Death-receptor O-glycosylation controls tumor-cell sensitivity to the proapoptotic ligand Apo2L/TRAIL

Defect induced ferromagnetism in undoped ZnO nanoparticles

Combination of Defects Plus Mixed Valence of Transition Metals: A Strong Strategy For Ferromagnetic Enhancement in ZnO Nanoparticles

Correlation between saturation magnetization, bandgap, and lattice volume of transition metal (M=Cr, Mn, Fe, Co, or Ni) doped Zn1−xMxO nanoparticles

Increased exposure to loading is associated with decreased plantar soft tissue hardness in people with diabetes and neuropathy

Carrier-controlled ferromagnetism in transparent oxide semiconductors

Room-temperature ferromagnetism in chemically synthesized Sn1−xCoxO2 powders

Flow diagram of the metal-insulator transition in two dimensions

Plasma Induced Transcriptional Analysis Assessment of Rejection in Pediatric Heart Transplantation

whole-genome RNAi screen identifies an 8q22 gene cluster that inhibits death receptor-mediated apoptosis

Efficacy of venetoclax as targeted therapy for relapsed/refractory t(11;14) multiple myeloma

Dopant spin states and magnetism of Sn1−xFexO2 nanoparticles

Venetoclax or placebo in combination with bortezomib and dexamethasone in patients with relapsed or refractory multiple myeloma (BELLINI): a randomised, double-blind, multicentre, phase 3 trial

Possible metamagnetic origin of ferromagnetism in transition-metal-doped SnO2

Development of high-temperature ferromagnetism in SnO2 and paramagnetism in SnO by Fe doping

Effect of Co doping on the structural, optical and magnetic properties of ZnO nanoparticles

Suchergebnisse filtern